Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Baxter Redaction and Interest

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Sep 11, 2023 11:46pm

145 Views

Post# 35630672

RE:RE:Baxter Redaction and Interest

Thx for your thoughts Chester

I believe that Eden has many functions including:

-recruitment ( enrolment acceleration )

-label expansion ( future revenues)

-dose determination (future revenues)

- etc.

I also think that Baxter is exerting more influence on timing and SP than we know

MM

<< Previous

Bullboard Posts

Next >>

Invest wiser with BMO's InvestorLine Platform features